cAMP regulates nitric oxide production and ouabain sensitive Na+, K+- ATPase activity in SH-SY5Y human neuroblastoma cells

Diabetologia

Volumn 41, Issue 12, 1998, Pages 1451-1458

  Inada, H ^a   Shindo, H ^a   Tawata, M ^a   Onaya, T ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cyclic AMP; Cyclic GMP; Diabetic neuropathy; Human neuroblastoma cells; Nitric oxide; Nitrite; Protein kinase A; Sodium potassium ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); CYCLIC AMP; CYCLIC GMP; GLUCOSE; INOSITOL; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; OUABAIN; PROTEIN KINASE C; SORBITOL;

ARTICLE; CELL CULTURE; DATA ANALYSIS; DIABETIC RETINOPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; NEUROBLASTOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; STATISTICAL ANALYSIS;

BUCLADESINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; ENZYME INHIBITORS; EPOPROSTENOL; HUMANS; ISOQUINOLINES; KINETICS; NA(+)-K(+)-EXCHANGING ATPASE; NEUROBLASTOMA; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRITES; OUABAIN; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0031741965     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051091     Document Type: Article

References (53)

1. Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168-188
2. +-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 37: 688-693
3. Greene DA, Sima AAF, Stevens MJ et al. (1993) Aldose reductase inhibitors. An approach to the treatment of diabetic nerve damage. Diabetes Metab Rev 9: 189-217
4. Dyck PJ, Hansen S, Karnes J et al. (1985) Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82: 2513-2517
5. Young MJ, Veves A, Walker MG, Boulton AJM (1992) Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 35: 1146-1150
6. Brownlee M (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15: 1835-1842
7. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J Clin Invest 87: 432-438
8. Shindo H, Tawata M, Aida K, Onaya T (1992) The role of cyclic adenosine 3′,5′-monophosphate and polyol metabolism in diabetic neuropathy. J Clin Endocrinol Metab 74: 393-398
9. Shindo H, Tawata M, Onaya T (1993) Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved. J Endocrinol 136: 431-438
10. Shindo H, Tawata M, Onaya T (1993) Cyclic adenosine 3′, 5′-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats. Endocrinology 132: 510-516
11. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rats. J Clin Invest 94: 853-859
12. Shindo H, Thomas PT, Larkin DD et al. (1996) Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells. J Clin Invest 97: 736-745
13. Imai T, Hirata Y, Kanno K, Marumo F (1994) Induction of nitric oxide synthase by cAMP in rat vascular smooth muscle cells. J Clin Invest 93: 543-549
14. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Förstermann U (1996) In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-κB. J Biol Chem 271: 6039-6044
15. 15N] nitrate in biological fluids. Anal Biochem 126: 131-138
16. Raymond W, Nims JC, Cook MC et al. (1996) Colorimetric assay for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 268: 93-105
17. Homma M, Satoh K, Takezawa L, Ui M (1977) An ultrasensitive methods for the stimulators determination of cyclic AMP and cyclic GMP in small-volume sample from blood and tissue. Biochem Med 18: 257-273
18. Hegyvary C, Kang K, Bandi Z (1979) Automated assay of phosphohydrolases by measuring the released phosphate without deprotenization. Anal Biochem 94: 397-401
19. +-ATPase during maturation in vitro of primary cultured rat cerebral neurons. J Biochem 104: 349-354
20. Malone JI, Knox G, Benford S, Tedesco TA (1980) Red cell sorbitol. An indicator of diabetic control. Diabetes 29: 861-864
21. Aida K, Tawata M, Shindo H, Onaya T (1990) Clinical significance of erythrocyte sorbitol-blood glucose ratios in type II diabetes Mellitus. Diabetes Care 13: 461-467
22. Weissbach A (1974) Myoinositol. In: Bergmeyer HLJ (ed) Methods of Enzymatic Analysis, Verlag Chemie, Weinheim, pp 1333-1336
23. Smith PK, Krohn RI, Hermanson AK (1985) Measurement of protein using hichinchoninic acid. Anal Biochem 150: 76-85
24. Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T (1985) Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation. Arzneimittelforsch 35: 1816-1818
25. Påhlman S, Ödelstad L, Larsson E, Grotte G, Nilsson K (1981) Phenotypic change of human neuroblastoma cell in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer 28: 583-589
26. Åkerman KEO, Scott IG, Anderson LC (1984) Functional differentiation of human ganglion cell derived from neuroblastoma cell line SH-SY5Y induced by a phorbol ester (TPA). Neurochem Int 6: 77-80
27. Chijiwa T, Mishima A, Hagiwara M et al. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265: 5267-5272
28. Hidaka H, Sasaki Y, Tanaka T et al. (1981) N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci USA 78: 4354-4357
29. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752
30. 2+ modulation of myo-inositol transport in cultured retinal pigment epithelial cells. Am J Physiol 273:C671-C678
31. Furmanski P, Silverman DJ, Lubin M (1971) Expression of differentiated functions in mouse neuroblastoma mediated by dibutyryl-cyclic adenosine monophosphate. Nature 233: 413-415
32. Prasad KN, Sheppard JR (1972) Inhibitors of cyclic-nucleotide phosphodiesterase induce morphological differentiation of mouse neuroblastoma cell culture. Exp Cell Res 73: 436-440
33. +-ATPase and effects of site-directed mutagenesis. J Biol Chem 269: 9368-9373
34. Delamere NA, Socci RR, King KL (1990) Alteration of sodium potassium-adenosine triphosphatase activity in rabbit ciliary processes by cyclic adenosine monophosphate-dependent protein kinase. Invest Ophthalmol Vis Sci 31: 2164-2170
35. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol 266:H2146-H2151
36. +-ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J Clin Invest 90: 727-732
37. Scavone C, Scanlon C, Mckee M, Nathanson JA (1995) Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cGMP and cyclic GMP-dependent protein kinase. J Pharmacol Exp Ther 272: 1036-1043
38. Kihara M, Low PA (1995) Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 132: 180-185
39. Cameron NE, Cotter MA (1995) Effect of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetic rats. Eur J Clin Invest 25: 19-24
40. De Man JG, Pelckmans PA, Boeckxstaens GE et al. (1991) The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br J Pharmacol 103: 1092-1096
41. Toda N, Okamura T (1991) Role of nitric oxide in neurally induced cerebroarterial relaxation. J Pharmacol Exp Ther 258: 1027-1032
42. Meller ST, Pechman PS, Gebhart GF, Maves TJ (1992) Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 50: 7-10
43. Wu W, Liuzzi FJ, Schinco FP et al. (1994) Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 61: 719-726
44. Sekiguchi M., Morikawa A, Nakajima K et al. (1991) Clinical usefulness of cilostazol (pletaal) on diabetic neuropathy and serum lipid levels. Jpn Pharmacol Ther 19: 3273-3277
45. Okuda Y, Mizutani M, Isaka M et al. (1991) Hemodynamic effects of cilostazol on dorsalis pedis artery in patients with diabetic neuropathy. Jpn Pharmacol Ther 19: 4679-4689
46. 1 · α CD on vibratory threshold determined with the SMV-5 vibrometer in patients with diabetic neuropathy. Diabetes Res Clin Pract 24: 173-180
47. 1 on vibratory threshold in patients with diabetic neuropathy. Prostaglandins 49: 27-39
48. Shindo H, Tawata M, Aida K, Onaya T (1991) Clinical efficacy of a stable prostacyclin analog, Iloprost, in diabetic neuropathy. Prostaglandins 41: 85-96
49. Noda K, Umeda F, Nawata H (1996) Effect of bereprost sodium on response to test of autonomic control of heart rate in patients with diabetes mellitus. Diabetes Res Clin Pract 31: 119-124
50. Cameron NE, Cotter MA, Dines KC, Maxfield EK (1993) Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36: 516-522
51. Cameron NE, Cotter MA, Hohman TC (1996) Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 39: 172-182
52. +-ATPase activity, and vascular supply in STZ-D rats. Diabetes 40: 1652-1658
53. Robertson S, Cameron NE, Cotter MA (1992) The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 35: 1113-1117